The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Subgroup analysis of real-world efficacy of enfortumab vedotin in patients with metastatic/locally advanced urothelial carcinoma from a European database.
 
Christopher Darr
Honoraria - Bayer; Ipsen; Janssen
Consulting or Advisory Role - Ipsen; Janssen
Research Funding - Deutsche Forschungsgemeinschaft (Inst)
Travel, Accommodations, Expenses - Bayer; Ipsen; Janssen
 
Niklas Klümper
Stock and Other Ownership Interests - Bicycle Therapeutics; Daiichi Sankyo/UCB Japan; immatics; Pfizer
Honoraria - Astellas Pharma; MSD Oncology
Consulting or Advisory Role - Astellas Pharma; Eisai; MSD Oncology
Travel, Accommodations, Expenses - Ipsen; MSD Oncology; Photocure
 
Thomas Büttner
Honoraria - Astellas Pharma
Travel, Accommodations, Expenses - Ipsen; MSD
 
Nina Holzwarth
No Relationships to Disclose
 
Nadine Biernath
Consulting or Advisory Role - Accord Healthcare; Astellas Pharma; Hexal; Janssen Oncology; Pfizer
 
Alexander Höllein
No Relationships to Disclose
 
Guenter Niegisch
Honoraria - Astellas Pharma; AstraZeneca; BMS GmbH & Co. KG; Eisai Germany; Janssen Oncology; Medac; Pfizer; Roche Pharma AG
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Janssen Oncology; Merck/Pfizer; Pfizer; Roche Pharma AG
Travel, Accommodations, Expenses - AstraZeneca; Janssen Oncology; Roche
 
Daniel Seidl
No Relationships to Disclose
 
Analena Handke
No Relationships to Disclose
 
Pia Paffenholz
Honoraria - BMS GmbH & Co. KG; Eisai; Janssen; Merck
Consulting or Advisory Role - Janssen; Merck; Roche
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Ipsen; Janssen; Medac; Merck
 
Katrin Schlack
Honoraria - AAA HealthCare; Amgen (Inst); Astellas Pharma; AstraZeneca; Bayer Germany; Eisai Germany; Fosanis; Ipsen; Janssen; Merck Serono; MSD; Novartis; Pfizer
Consulting or Advisory Role - Apogepha; Bayer; BMS GmbH & Co. KG; Ipsen; Janssen; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Ipsen; Janssen; Pfizer
 
Richard Cathomas
Honoraria - Astellas Pharma (Inst); Janssen-Cilag; Merck KGaA (Inst)
Consulting or Advisory Role - Accord Healthcare (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Janssen-Cilag; MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sandoz (Inst)
Travel, Accommodations, Expenses - Ipsen (Inst)
 
Eva Erne
Travel, Accommodations, Expenses - Pfizer
 
Severine Banek
No Relationships to Disclose
 
Robert Tauber
No Relationships to Disclose
 
Jozefina Casuscelli
Research Funding - AstraZeneca (Inst); MSD Oncology (Inst)
Expert Testimony - Astellas Pharma; Janssen Cilag; MSD Oncology
Travel, Accommodations, Expenses - Bayer; Janssen Oncology; Merck KGaA; Pfizer
 
Anna Katharina Seitz
No Relationships to Disclose
 
Boris A. Hadaschik
Consulting or Advisory Role - ABX Advanced biochemical compounds; Accord Healthcare; Amgen; Astellas Pharma; Bayer; BMS GmbH & Co. KG; Ipsen; Janssen; Lightpoint medical; Merck KGaA; MSD; Novartis; Onkowissen; Pfizer; POINT Biopharma
Research Funding - Bristol Myers Squibb (Inst); Janssen; Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Uromed
Travel, Accommodations, Expenses - AstraZeneca; Bayer; BMS; Ipsen; Janssen
 
Viktor Grünwald
Employment - University Hospital Essen
Stock and Other Ownership Interests - AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Genmab; MSD
Honoraria - Advanced Accelerator Applications/Novartis; Amgen; Apogepha; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Ipsen; Janssen-Cilag; Merck Serono; MSD Oncology; Ono Pharmaceutical; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Cureteq; Debiopharm Group; Eisai; Gilead Sciences; Ipsen; Janssen-Cilag; MSD Oncology; Novartis; Oncorena; PCI Biotech; Pfizer; Synthekine
Research Funding - Amgen (Inst); Bicycle Therapeutics (Inst); BMS (Inst); Gilead Sciences (Inst); Ipsen (Inst); MSD Oncology (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Janssen; Merck Serono; Pfizer
 
Stefanie Zschaebitz
Honoraria - Amgen; Astellas Pharma; Bayer; BMS GmbH & Co. KG; Eisai Germany; Ipsen; Janssen Oncology; Merck Serono; MSD Oncology; Novartis; Pfizer (Inst)
Consulting or Advisory Role - Amgen; Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai; EUSA Pharma; Gilead Sciences; Ipsen; Merck; MSD Oncology; Pfizer (Inst); Roche; Sanofi/Aventis (Inst)
Research Funding - Eisai (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; BMS GmbH & Co. KG; Ipsen; Janssen Oncology; Merck; Pfizer